Skip to content
AwardedSpainGoods€2,866,406

SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS OMAVELOXOLONA DE BIOGEN SPAIN, PARA EL HOSPITAL UNIVERSITARIO DE FUENLABRADA

Published
Published 2 July 2026

Overview

Hospital Universitario de Fuenlabrada has awarded a contract to BIOGEN SPAIN, S.L. for the supply of exclusive omaveloxolone medication. The contract, valued at €1,302,912, was awarded on 24 June 2026.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€2,866,406
Procedure
Direct
Published
2 July 2026
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€1,302,912
Award date
24 June 2026
Winner
  • BIOGEN SPAIN, S.L.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    2 July 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS OMAVELOXOLONA DE BIOGEN SPAIN, PARA EL HOSPITAL UNIVERSITARIO DE FUENLABRADA — won by BIOGEN SPAIN, S.L. — Skim